Cas:207516-23-2 tert-butyl (4S,5R,1’E)-4-(hydroxymethyl)-2,2-dimethyl-5-(pentadec-1′-enyl)-oxazolidine-3-carboxylate manufacturer & supplier

We serve Chemical Name:tert-butyl (4S,5R,1’E)-4-(hydroxymethyl)-2,2-dimethyl-5-(pentadec-1′-enyl)-oxazolidine-3-carboxylate CAS:207516-23-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

tert-butyl (4S,5R,1'E)-4-(hydroxymethyl)-2,2-dimethyl-5-(pentadec-1'-enyl)-oxazolidine-3-carboxylate

Chemical Name:tert-butyl (4S,5R,1’E)-4-(hydroxymethyl)-2,2-dimethyl-5-(pentadec-1′-enyl)-oxazolidine-3-carboxylate
CAS.NO:207516-23-2
Synonyms:(4S,5R)-4-Hydroxymethyl-2,2-dimethyl-5-((E)-pentadec-1-enyl)-oxazolidine-3-carboxylic acid tert-butyl ester;(4S,5R,1E)-tert-butyl-4-(hydroxymethyl)-2,2-dimethyl-5-(pentadec-1-enyl)-oxazolidine-3-carboxylate
Molecular Formula:C26H49NO4
Molecular Weight:439.67200
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:59.00000
Exact Mass:439.36600
LogP:6.91450

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like (4S,5R)-4-Hydroxymethyl-2,2-dimethyl-5-((E)-pentadec-1-enyl)-oxazolidine-3-carboxylic acid tert-butyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(4S,5R,1E)-tert-butyl-4-(hydroxymethyl)-2,2-dimethyl-5-(pentadec-1-enyl)-oxazolidine-3-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(4S,5R,1E)-tert-butyl-4-(hydroxymethyl)-2,2-dimethyl-5-(pentadec-1-enyl)-oxazolidine-3-carboxylate Use and application,(4S,5R)-4-Hydroxymethyl-2,2-dimethyl-5-((E)-pentadec-1-enyl)-oxazolidine-3-carboxylic acid tert-butyl ester technical grade,usp/ep/jp grade.


Related News: In a statement to Fierce Medtech, Innova said it has completed some corrective actions, while others are still underway, and that the U.S. recall was launched to reclaim tests distributed to employees, clinical studies and to customers for early evaluation. The company said it plans to seek an emergency use authorization and comply with all FDA requirements. tert-butyl (4S,5R,1’E)-4-(hydroxymethyl)-2,2-dimethyl-5-(pentadec-1′-enyl)-oxazolidine-3-carboxylate manufacturer In a statement to Fierce Medtech, Innova said it has completed some corrective actions, while others are still underway, and that the U.S. recall was launched to reclaim tests distributed to employees, clinical studies and to customers for early evaluation. The company said it plans to seek an emergency use authorization and comply with all FDA requirements. tert-butyl (4S,5R,1’E)-4-(hydroxymethyl)-2,2-dimethyl-5-(pentadec-1′-enyl)-oxazolidine-3-carboxylate supplier Alira’s work spans the gamut from transaction advisory to regulatory services to advanced analytics, management consulting, product development and clinical investigator training, to name a few. With the CROS NT deal, Alira secures not only a biometrics presence but also a portfolio of electronic data capture systems. tert-butyl (4S,5R,1’E)-4-(hydroxymethyl)-2,2-dimethyl-5-(pentadec-1′-enyl)-oxazolidine-3-carboxylate vendor There’s a few factors that play into this. tert-butyl (4S,5R,1’E)-4-(hydroxymethyl)-2,2-dimethyl-5-(pentadec-1′-enyl)-oxazolidine-3-carboxylate factory In a statement to Fierce Medtech, Innova said it has completed some corrective actions, while others are still underway, and that the U.S. recall was launched to reclaim tests distributed to employees, clinical studies and to customers for early evaluation. The company said it plans to seek an emergency use authorization and comply with all FDA requirements.